SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-019927
Filing Date
2022-05-12
Accepted
2022-05-12 17:10:53
Documents
52
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q etnb-10q_20220331.htm   iXBRL 10-Q 1813873
2 EX-31.1 etnb-ex311_7.htm EX-31.1 20138
3 EX-31.2 etnb-ex312_8.htm EX-31.2 20151
4 EX-32 etnb-ex32_6.htm EX-32 15933
  Complete submission text file 0001564590-22-019927.txt   6568276

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA etnb-20220331.xsd EX-101.SCH 36468
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE etnb-20220331_cal.xml EX-101.CAL 43256
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE etnb-20220331_def.xml EX-101.DEF 131472
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE etnb-20220331_lab.xml EX-101.LAB 345871
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE etnb-20220331_pre.xml EX-101.PRE 244437
46 EXTRACTED XBRL INSTANCE DOCUMENT etnb-10q_20220331_htm.xml XML 1270976
Mailing Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104
Business Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104 (415) 432-9270
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

IRS No.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39122 | Film No.: 22918923
SIC: 2834 Pharmaceutical Preparations